Previous 10 | Next 10 |
2024-02-22 22:17:14 ET Summary Chase Coleman's Tiger Global Management 13F portfolio value increased from $13.56B to $14.05B this quarter. The largest five positions in the portfolio are Meta Platforms, Microsoft, Apollo Global, Take-Two Interactive, and Amazon.com. New stakes...
2024-02-22 21:01:24 ET Summary Novo Nordisk had a near perfect FY23. Fundamentally, FY24 should look quite similar. In reviewing FY23 results and commentary, we discuss key points like SELECT outcomes; CagriSema progress; and expansion into cardiovascular disease. Though expen...
2024-02-22 14:41:34 ET More on Amgen, Eli Lilly, etc. Pfizer's Post-Pandemic Pivot Pfizer: Turnaround Is Gaining Momentum Eli Lilly: Yes, It Is Too Late To Join The Party Novo to face Wegovy competition in India as local versions loom: Reuters Weight-...
2024-02-21 17:56:59 ET Eli Lilly (NYSE: LLY) has become a true behemoth of a healthcare stock, but it lost a bit of bulk on Hump Day. Investors traded out of the shares, and they closed the day more than 1% lower, in contrast to the slight (0.1%) increase of the S&P 500 inde...
2024-02-21 14:33:40 ET Weight Watchers ( NASDAQ: WW ) is losing ground for a second day as the fallout from the “Weight Watchers GLP-1 House” continues to weigh on the stock.... Read the full article on Seeking Alpha For further details see: Weight Watc...
2024-02-21 11:26:20 ET More on Ventyx Biosciences Ventyx: Too Risky Right Now After Some Poor Data Seeking Alpha’s Quant Rating on Ventyx Biosciences Historical earnings data for Ventyx Biosciences Financial information for Ventyx Biosciences ...
2024-02-21 08:30:26 ET Summary Eaton Vance Tax-Managed Diversified Equity Income Fund and Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund utilize a call-writing strategy to help deliver investors monthly distributions. Both ETY and ETW focus on dividend-paying stocks a...
2024-02-21 06:58:45 ET Summary The iShares S&P 100 ETF consistently outperforms the broad market, represented by the Vanguard S&P 500 ETF. Ordinary investors often fail to achieve the total returns of the S&P 500 due to mistakes like trying to time the market or over-e...
2024-02-21 06:39:00 ET Over the last year, Eli Lilly 's (NYSE: LLY) stock is up nearly 120%. This monstrous move has helped propel the pharmaceutical leader to become the largest health care company in the world by market cap. Although Lilly has a number of medications in its po...
2024-02-20 15:45:00 ET Summary Eli Lilly's stock has seen a parabolic rise, with recent gains driven by retail buying, a surge in call option demand, and short covering, taking valuations to extreme levels. The stock is trading at 83x earnings, which is 4.2x the average of the res...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...